2706, 2019
Phyton Biotech Receives Patent for the Production of Ingenol-3-angelate, Using Plant Cell Fermentation (PCF®)
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
1804, 2019
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
3101, 2019
Phyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy
Phyton Biotech partners with PellePharm.
301, 2019
Phyton Biotech Partners with Agenus to Revolutionize QS-21 Production
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
1112, 2018
Phyton Biotech Announces Appointment of New General Manager
Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
2112, 2017
Phyton Biotech Unifies International Operations Under New Leadership
DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.